| Literature DB >> 34721836 |
Sara Emmanouilidis1, Madeleine E Hackney2,3, Susan C Slade1, Hazel Heng1, Dana Jazayeri1, Meg E Morris1,4.
Abstract
OBJECTIVE: To evaluate the outcomes of face-to-face, digital, and virtual modes of dancing for people living with Parkinson's disease (PD).Entities:
Year: 2021 PMID: 34721836 PMCID: PMC8556098 DOI: 10.1155/2021/7516504
Source DB: PubMed Journal: Parkinsons Dis ISSN: 2042-0080
Medline search.
| Search ID# | Search terms | Search notes | Results |
|---|---|---|---|
| 1 | Exp Parkinson disease, secondary/or exp Parkinson disease/ | 70995 | |
| 2 | Parkinson∗.mp. | 127920 | |
| 3 | Exp stroke/or exp stroke rehabilitation/ | 136433 | |
| 4 | (Stroke or strokes).mp. | 295325 | |
| 5 | Exp Multiple sclerosis/ | 58198 | |
| 6 | “Multiple sclerosis”.mp. | 82515 | |
| 7 | 1 or 2 or 3 or 4 or 5 or 6 | 519376 | |
| 8 | Exp dance therapy/ | 359 | |
| 9 | Exp dancing/ | 2848 | |
| 10 | (Dance∗ or dance-based or dancing).mp. | 7345 | |
| 11 | (Foxtrot or tango or Waltz or “Irish set” or ballroom or ballet).mp. | 2113 | |
| 12 | Or/8–11 | Dance related terms | 8348 |
| 13 | Exp exercise movement techniques/ | 8116 | |
| 14 | physiotherap∗.mp. | 26124 | |
| 15 | Exp exercise therapy/ | 50130 | |
| 16 | Exp exercise/ | 192926 | |
| 17 | exercis∗.ti,ab. | 290086 | |
| 18 | Or/13–17 | Exercise/physio related terms | 431332 |
| 19 | 12 or 18 | Included dance and physio/exercise terms | 438077 |
| 20 | Exp telemedicine/or exp telerehabilitation/ | 27950 | |
| 21 | telerehabilitation.mp. | 933 | |
| 22 | tele.mp. | 3173 | |
| 23 | (Remote adj3 rehabilitat∗).mp. | 87 | |
| 24 | telehea∗.mp. | 4922 | |
| 25 | app.mp. | 25736 | |
| 26 | ((Exercise or mode) adj2 delivery).mp. | 8376 | |
| 27 | virtual.mp. | 59008 | |
| 28 | video.mp. or exp video recording/or tape recording/or videotape recording/ | 148947 | |
| 29 | (Online or “online”).ti,ab. | 137403 | |
| 30 | telemedicine.mp. | 27556 | |
| 31 | Exp telemedicine/ | 27950 | |
| 32 | (Telemonitor∗ or tele-monitor∗).mp. | 1706 | |
| 33 | Internet.mp. | 102501 | |
| 34 | ((Tele∗ adj2 coach∗) or telecoach∗).mp. | 374 | |
| 35 | videoconferenc∗.mp. | 2843 | |
| 36 | ipad.mp. | 1300 | |
| 37 | computer.mp. | 693528 | |
| 38 | Exp internet/or exp internet-based intervention/ | 78406 | |
| 39 | Mobile applications/ | 5683 | |
| 40 | (Apps or “mobile applications”).mp. | 10631 | |
| 41 | zoom.mp. | 1600 | |
| 42 | webinar∗.mp. | 569 | |
| 43 | (Live adj2 stream∗).mp. | 148 | |
| 44 | Web-based.mp. | 30097 | |
| 45 | Pre-record∗.mp. | 363 | |
| 46 | (Dvd adj2 deliv∗).mp. | 31 | |
| 47 | Or/20–46 | 1110851 | |
| 48 | 7 and 19 and 47 | Final results | 1903 |
| 49 | recorded.mp. | 525831 | |
| 50 | synchronous.mp. | 35231 | |
| 51 | asynchronous.mp. | 9988 | |
| 52 | 49 or 50 or 51 | 566263 | |
| 53 | 7 and 19 and 52 | Testing results for synchronous/asynchronous. | |
| Or recorded | 1204 |
Figure 1PRISMA flow diagram.
Study characteristics.
| First author, year | Study design | Sample size | Interventions | Age (years) mean ± SD | H&Y mean ± SD, range, or median (IQR) | Session length, frequency, intervention duration | Medications | Outcome measures | |
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| Duncan and Earhart, 2012 [ | RCT | 62 | Argentine Tango | 69.3 ± 1.9 | 2.6 ± 0.1 | 1 hr class, 2/week, 12 months | Not reported but tested in the “off phase” | UPDRS-II, UPDRS-III, FOG, 6MWT, MiniBEST, gait velocity | |
| Control, no dance | 69.0 ± 1.5 | 2.5 ± 0.1 | |||||||
| Duncan and Earhart, 2014 [ | RCT | 10 | Argentine Tango | 67.8 ± 8.72 | 2.4 | 1 hr, 2/week, 2 years | Levodopa | UPDRS-I, UPDRS-II, UPDRS-III, MiniBEST, gait velocity, TUG, dual-task TUG, 6MWT, FOGQ | |
| Control, no dance | 66 ± 11.0 | 2.3 | |||||||
| Kunkel et al., 2017 [ | RCT | 51 | Dance (mixed genre) | 71.3 ± 7.7 | 1–3 | 1 hr, 2/week, 10 weeks | Not reported | BBS, SS180, TUG, 6MWT, Phone-FITT, EQ-5D, ABC | |
| Control, no dance | 69.7 ± 6.0 | 1–3 | |||||||
| Hackney and Earhart, 2010 [ | RCT | 39 | Partner dancing | 69.6 ± 8.5 | 2-3 | 1 hr, 2/week, 10 weeks | Levodopa | UPDRS-III, BBS, tandem stance, one leg stance, TUG, 6MWT, gait measures | |
| Nonpartner dancing | 69.6 ± 9.5 | 2-2.6 | |||||||
| Hackney and Earhart, 2009 [ | RCT | 58 | Waltz/foxtrot | 66.8 ± 2.4 | 2.0 ± 0.2 | 1 hr, 2/week, 13 weeks | Levodopa | UPDRS-III, BBS, TUG, 6MWT, gait measures, FOGQ | |
| Tango | 68.2 ± 1.4 | 2.1 ± 0.1 | |||||||
| Control, no dance | 66.5 ± 2.8 | 2.2 ± 0.2 | |||||||
| Hackney et al., 2007 [ | RCT | 19 | Tango | 72.6 ± 2.20 | 2.3 ± 0.7 | 1 hr, 2/week, 13 weeks | PD medications | UPDRS-III, BBS, gait velocity, TUG, FOGQ | |
| Group exercise class | 69.6 ± 2.1 | 2.2 ± 0.6 | |||||||
| Hashimoto et al., 2015 [ | Quasi-RCT | 46 | PD dance | 67.9 ± 7.0 | Score 2 (11) | 60 min class, 1/week, 12 weeks | Not reported | TUG, BBS, UPDRS, SDS, FAB, Mental Rotation Task, Apathy Scale | |
| PD exercise | 62.7 ± 14.9 | Score 3 (33) | 60 min class, 1/week, 12 weeks | ||||||
| Control, usual care | 69.7 ± 4.0 | Score 4 (2) | |||||||
| Lee et al., 2015 [ | RCT | 20 | Virtual reality dance | 68.4 ± 2.9 | Not reported | 30 mins, 5/week, 6 weeks | Not reported | BBS, BDI, MBI | |
| Control | 70.1 ± 3.3 | ||||||||
| Lee et al., 2018 [ | RCT with cross-over design | 32 | Qigong dance | 65.8 ± 7.2 | 1–3 | 60 min, 2/week, 8 weeks | Not reported | UPDRS, PDQL, BBS, BDI | |
| Control, wait list | 65.7 ± 6.4 | 1–3 | |||||||
| McKee and Hackney, 2013 [ | Sequential RCT | 33 | Tango | 68.4 ± 7.5 | 2.3 (2.0-2.6) | 90 mins, 20 sessions, 12 weeks | PD medications | UPDRS-III, Four-Square Step Test, TUG, dual-task TUG, PDQ-39, FOGQ, SFHS-12 | |
| Lecture series | 74.4 ± 6.5 | 2.0 (2.0- 2.0) | |||||||
| Michels et al., 2018 [ | Pilot RCT | 13 | Dance therapy | 69.2 ± 8.7 (total) | 2.11 ± 0.33 | 60 mins, 1/week, 10 weeks | Stable PD medication regimen | UPDRS, MOCA, TUG, BBS, BDI, FSS, Visual Analog Fatigue Scale, PDQ-39 | |
| Control, support group | |||||||||
| Poier et al., 2019 [ | Pilot RCT | 29 | Argentine Tango | 68.50 ± 8.07 | Not reported | 60 min class, 1/week, 10 weeks | Not reported | PDQ-39, BMLSS, ICPH | |
| Control, Tai Chi | 68.87 ± 10.96 | ||||||||
| Rocha et al., 2018 [ | Pilot RCT | 21 | Argentine Tango | 70.2 ± 5.5 | 1–4 | In-person: 1 hour, 1/week | PD medication | TUG, BBS, functional gait assessment, FOGQ, UPDRS-II and -III, PDQ-39 | |
| Mixed dance | 72.9 ± 5.5 | ||||||||
| Rio Romenets et al., 2015 [ | RCT | 33 | Argentine Tango | 63.2 ± 9.9 | 2 ± 0.5 | 1 hr, 2/week, 12 weeks | Not reported | UPDRS-III, UPDRS, MiniBEST, TUG, dual-task TUG, BDI, Apathy Scale, KFSS, PDQ-39, CGI-C, FOGQ, Falls Questionnaire, MOCA | |
| Control | 64.3 ± 8.1 | 1.7 ± 0.6 | |||||||
| Shanahan et al., 2017 [ | RCT | 41 | Set dancing | 69 ± 10 | 1.25 ± 1 | In-person: 1 hr, 1/week | Not reported | UPDRS-III, 6MWT, MiniBEST, PDQ-39 | |
| Control, usual care and ADL | 69 ± 8 | 2 ± 1 | Home: 20 mins, 3/week, 10 weeks | ||||||
| Solla et al., 2019 [ | RCT | 20 | Sardinian folk dance | 67.8 ± 5.9 | 2.1 ± 0.6 | 90 mins, 2/week, 12 weeks | PD medications | UPDRS-III, 6MWT, BBS, TUG, Parkinson's Disease Fatigue Scale, BDI, Starkstein Apathy Scale, MOCA | |
| Control, usual care | 67.1 ± 6.3 | 2.3 ± 0.4 | |||||||
| Volpe et al., 2013 [ | RCT: single blind, parallel group | 24 | Intervention: Irish set dancing | 61.6 ± 4.5 | 2.2 ± 0.4 | 90 min classes, 1/week, 6 months | Levodopa (n=24) | UPDRS-III, BBS, FOG, PDQ-39 | |
| Control: physiotherapy (balance, cueing, gait training, strength) | 65.0 ± 5.3 | 2.2 ± 0.4 | 90 mins, 1/week, 6 months, 1 hr weekly home video | ||||||
|
| |||||||||
| Albani et al., 2019 [ | Single group, pre-post design, feasibility | 10 | Tango-based home exercises and group sessions | 63.1 ± 9.25 | 2-3 | Home: 1 hr, 4/week, 5 weeks | Not reported | Gait measures (fully cued visual four-choice reaction-time tasks, simple reaction-time task, an uncued task, two partially cued tasks), UPDRS | |
| Batson, 2010 [ | Single group, pre-post design | 11 | Modern dance | 72.7 + 8.7 | 1-2.5 | 85 min class 3/week, 3 weeks | Sinemet n=7, | TUG, FAB | |
| Blandy et al., 2015 [ | Single group, pre-post design | 6 | Argentine Tango | 64 ± 6.28 | 2 (2-2) | 1 hr, 2/week, 4 weeks | “ON” phase of medication | EQ-5D, Visual Analogue Scale, BDI | |
| Dahmen-Zimmer and Jansen, 2017 [ | Pre-post design, pilot trial | 37 | Karate (Shotokan) | 68.87 ± 7.24 | 1–3 | 1 hr, 1/week, 30 weeks | Not reported | Multidimensional Mood State Questionnaire, Hospital Anxiety and Depression Scale, CEDS Depression Scale, SFHS-12, Short Scale Of General Self-Efficacy | |
| Dance (mixed genre) | 72.33 ± 6.69 | ||||||||
| Control (waitlist) | 70.42 ± 10.07 | ||||||||
| Delextrat et al., 2016 [ | Single group, pre-post design, feasibility | 11 | Zumba | 64.0 ± 8.1 | <3 | 45 mins–1 hr, 1/week, 6 weeks | Not reported | Enjoyment, change in physical activity, exercise intensity (accelerometry), heart rate, rated perceived exertion | |
| Hackney and Earhart, 2009 [ | Single group, pre-post design | 14 | Argentine Tango | 67.2 ± 9.6 | 2.4 (25%:2.0; 75%:2.5) | 1.5 hrs, 5/week, 2 weeks | Not reported | UPDRS-III, BBS, TUG, 6MWT, gait measures | |
| Hackney and McKee, 2014 [ | Single group, pre-post, pilot trial | 88 | Argentine Tango (PD) | 68.4 ± 7.5 | 1–3 | 1.5 hrs, 2/week for 12 weeks | PD medication | UPDRS-III, BBS, TUG, gait speed assessment, 30 second chair stand, tandem stance | |
| Older adults (non-PD) | 82.3 ± 8.8 | ||||||||
| Heiberger et al., 2011 [ | Single group, pre-post design | 11 | Mixed genre dance | 71.3 ± 8.4 | Moderate to severe 2.5–4 | 1/week class, 8 months | L-Dopa or dopamine agonists | UPDRS-III, TUG, QOLS, Westheimer Questionnaire | |
| Kalyani et al., 2019 [ | Quasiexperimental design | 33 | Dance (mixed genre) | 65.24 ± 11.88 | 1.65 ± 0.79 | 1 hr, 2/week, 12 weeks | Not reported | UPDRS-I, UPDRS-II, PDQ39 | |
| Control | 66.50 ± 7.70 | 1.56 ± 0.81 | |||||||
| Listewnik and Ossowski, 2018 [ | Single group, pre-post design | 10 | Dance | 69.9 ± 6.47 | — | 70 mins, 2/week for 12 weeks | Not reported | Tinetti POMA Test, TUG, 6MWT | |
| McGill et al., 2018 [ | Non-RCT | 32 | Ballet | 69.83 ± 4.55 | 2.32 ± 0.48 | 1.25-1.5 hrs, 1/week for 1 year | Not reported | Step and stride variability, ABC | |
| Control | 73.25 ± 8.09 | 2.15 ± 0.55 | |||||||
| McKay et al., 2016 [ | Single group study | 22 | Adapted Tango | 65.4 ± 12.8 | 1–4 | 90 mins, 15 lessons over 3 weeks | Not reported | UPDRS, dyskinesia, BBS, Dynamic Gait Index, FAB, musculoskeletal health, 6MWT, single and dual-task TUG, fast and preferred cadence, ABC, FOGQ | |
| McNeely et al., 2015 [ | Pre-post design | 16 | Dancing for PD (mixed genre) | 68.25 ± 10.90 | 2.25 ± 0.27 | 1 hr group class, 2/week, 12 weeks | Levodopa | UPDRS-III, MiniBEST, TUG, dual-task TUG, 6MWT, gait velocity | |
| 67.66 ± 8.62 | 2.13 ± 0.58 | ||||||||
| McRae et al., 2018 [ | Exploratory study, surveys | 61 | Dancing for Parkinson's Disease (mixed genre) | 67 ± 13 | 1–4 | 1-2/week, 12 months (6months–2 years), session length unknown | Not reported | 36-Item Short Form Health Survey, Self-Efficacy Scale, functional mobility | |
| Marchant et al., 2010 [ | Single group, pre-post design | 11 | Improvisation dance | 71.2 ± 6.1 | 2.4 ± 0.4 | 10 1.5-hour classes, 2 weeks | PD medication | UPDRS-III, BBS, TUG, gait measures, Five Times Sit-to-Stand Test, 6MWT, FOGQ, ABC, PDQ-39 | |
| Rawson et al., 2019 [ | Nonrandomised controlled | 96 | Tango vs treadmill vs control (stretching) | 67.2 ± 8.9 | 1–4 | 1 hr class, 2/week, 12 weeks | Levodopa | UPDRS-III, PDQ-39, 6MWT, MiniBEST, gait measures | |
| Seidler et al., 2017 [ | Non-RCT | 26 | Telerehab dance | 68.1 ± 7.9 | 1–3 | 1 hr, 2/week, 12 weeks | Not reported | MiniBEST, UPDRS-III, gait velocity | |
| In-person dance | 68.9 ± 9.4 | ||||||||
| Shanahan et al., 2015 [ | Single group, pre-post pilot trial | 10 | In-person and home-based dance programs | 66.66 ± 5.87 | 1.5 ± 0.5 | In-person: 1.5 hrs. 1/week | Not reported | UPDRS, 6MWT, BBS | |
| Tillmann et al., 2020 [ | Non-RCT | 47 | Brazilian samba | 67 ± 9.2 | 1.8 ± 0.7 | 1 hr, 2/week, 12 weeks | 4 months stable medication | PDQ-39, PDSS, BDI, FSS, UPDRS-I | |
| Control | 69.6 ± 9.5 | ||||||||
| Tunur et al., 2020 [ | Pre-post -mixed methods | 7 | Google glass dance modules | 69 ± 5.5 | 2–3 | 3+ modules/day, 3 weeks. Session length not reported | Not reported | MiniBEST, one leg stance, TUG, dual-task TUG, ABC, BDI, PDQL | |
| Zafar et al., 2017 [ | Pre-post design | 88 | Adapted Tango (PD) | 68.4 ± 8 | 1–3 | 90 min, 2/week, 12 weeks | PD medication | Fear of falling, quality of life, composite physical function, MOCA, BDI, UPDRS-III, gait velocity, Impact on Participation and Autonomy Questionnaire | |
| Adapted Tango (non-PD) | 82.3 ± 9 | ||||||||
Note: 6MWT, Six-Minute Walk Test; ABC, Activities-Specific Balance Confidence Scale; BBS, Berg Balance Scale; BDI, Beck Depression Inventory; EQ-5D, EuroQol-5 Dimension; FAB, Fullerton Advance Balance Scale; FOGQ, Freezing of Gait Questionnaire; FSS, Fatigue Severity Scale; HADS, Hospital Anxiety and Depression Scale; KFSS, Krupp Fatigue Severity Scale; MiniBEST, Mini-Balance Evaluation Systems Test; MBI, Modified Barthel Index; MOCA, Montreal Cognitive Assessment; PDQ-39, Parkinson's Disease Questionnaire-39; PDSS, Parkinson's Disease Sleep Scale; RCT, Randomised Controlled Trial; SDS, Self-Rating Depression Scale; SFHS-12, Short Form Health Survey-12; SS180, Standing-Start 180° Turn Test; Tinetti POMA Test, Tinetti Performance-Oriented Mobility Assessment Test; TUG, Timed Up and Go; UPDRS, Unified Parkinson's Disease Rating Scale.
Method quality appraisal of included studies.
|
| |||||||||||
| First author, year | Random allocation | Concealed allocation | Baseline-similar | Blinded participant | Blinded therapist | Blinded assessor | Measures for >85% sample | ITT | Between group analysis | Outcome measure data | Score/10 |
| Duncan and Earhart, 2012 [ | Y | Y | Y | N | N | Y | N | Y | Y | Y | 7 |
| Duncan and Earhart, 2014 [ | Y | N | Y | N | N | Y | N | N | Y | Y | 5 |
| Hackney and Earhart, 2010 [ | Y | N | Y | N | N | Y | N | Y | Y | Y | 6 |
| Hackney and Earhart, 2009 [ | Y | N | Y | N | N | Y | N | N | Y | Y | 5 |
| Hackney et al., 2007 [ | Y | N | Y | N | N | Y | N | N | Y | Y | 5 |
| Hashimoto et al., 2015 [ | Y | Y | Y | N | N | Y | N | N | Y | Y | 6 |
| Kunkel et al., 2017 [ | Y | N | Y | N | N | Y | Y | N | Y | Y | 6 |
| Lee et al., 2015 [ | Y | N | Y | N | N | N | N | N | Y | Y | 4 |
| Lee et al., 2018 [ | Y | Y | Y | N | N | Y | y | Y | Y | Y | 8 |
| McKee and Hackney, 2013 [ | N | N | Y | N | N | Y | N | N | Y | Y | 4 |
| Michels et al., 2018 [ | Y | N | Y | N | N | Y | Y | N | Y | Y | 6 |
| Poier et al., 2019 [ | Y | Y | Y | N | N | Y | Y | Y | Y | Y | 7 |
| Rocha et al., 2018 [ | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 10 |
| Rios Romenets et al., 2015 [ | Y | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Shanahan et al., 2017 [ | Y | Y | Y | N | N | Y | N | N | Y | Y | 6 |
| Solla et al., 2019 [ | Y | N | Y | N | N | Y | Y | N | Y | Y | 6 |
| Volpe et al., 2013 [ | Y | Y | Y | N | N | Y | N | N | Y | Y | 6 |
|
| |||||||||||
|
| |||||||||||
| First author, year | Cause effect | Participants similar | Comparisons similar | Control group | Multiple measures | Follow-up | Consistent measurement | Reliable measurement | Statistical analysis | Score/9 | |
| Albani et al., 2019 [ | Y | Y | N | N | Y | Y | Y | Y | Y | 7 | |
| Batson, 2010 [ | Y | Y | Y | N | N | Y | Y | Y | N | 6 | |
| Blandy et al., 2015 [ | N | Y | N | N | Y | N | Y | Y | Y | 5 | |
| Dahmen-Zimmer and Jansen, 2017 [ | Y | N | N | Y | Y | N | Y | Y | Y | 6 | |
| Delextrat et al., 2016 [ | Y | Y | N | N | Y | N | Y | Y | Y | 6 | |
| Hackney and Earhart, 2009 [ | Y | N | N | N | Y | N | N | Y | Y | 4 | |
| Hackney and McKee, 2014 [ | Y | N | N | N | Y | Y | N | Y | Y | 5 | |
| Heiberger et al., 2011 [ | Y | N | Y | N | Y | Y | Y | Y | N | 6 | |
| Kalyani et al., 2019 [ | Y | Y | N | Y | Y | Y | Y | Y | Y | 8 | |
| Listewnik and Ossowski, 2018 [ | Y | N | N | N | N | N | Y | N | Y | 3 | |
| McGill et al., 2018 [ | Y | Y | Y | Y | Y | N | Y | Y | Y | 8 | |
| McKay et al., 2016 [ | Y | Y | N | N | Y | Y | Y | Y | Y | 7 | |
| McNeely et al., 2015 [ | Y | Y | N | N | Y | N | Y | Y | Y | 6 | |
| McRae et al., 2018 [ | Y | N | N | N | Y | N | Y | Y | Y | 5 | |
| Marchant et al., 2010 [ | Y | N | Y | N | N | Y | Y | Y | Y | 6 | |
| Rawson et al., 2019 [ | Y | Y | Y | Y | Y | Y | Y | Y | Y | 9 | |
| Seidler et al., 2017 [ | Y | Y | N | N | Y | N | Y | Y | Y | 6 | |
| Shanahan et al., 2015 [ | Y | N | Y | N | Y | N | Y | Y | Y | 6 | |
| Tillmann et al., 2020 [ | Y | Y | Y | Y | N | N | Y | Y | Y | 7 | |
| Tunur et al., 2020 [ | N | Y | N | N | Y | Y | Y | Y | Y | 6 | |
| Zafar et al., 2017 [ | Y | N | Y | Y | Y | Y | Y | Y | Y | 8 | |
Note: Y=yes; N=no.
Data analysis for randomised controlled trials.
| Author (lead), year | Dependent variable | Outcome measure | Effect size | 95% Confidence interval (CI) | Dose of intervention |
|---|---|---|---|---|---|
| Duncan and Earhart (2012) [ | Disability-motor | UPDRS-motor 3 | −2.71 | −3.40 to −2.02 | 1 hr class, 2/week, 12 months |
|
| |||||
| Hackney and Earhart (2010) [ | Balance | Berg balance scale | −0.33 | −0.96 to 0.30 | 1 hr, 2/week, 10 weeks |
| Mobility | Timed up and go | 0.52 | −0.12 to 1.16 | ||
|
| |||||
| Hackney and Earhart (2009) [ | Disability | UPDRS | WF: −2.61 | −3.53 to −1.70 | 1 hr, 2/week, 13 weeks |
| T: −2.44 | −3.37 to −1.51 | ||||
| Balance | Berg balance scale | WF: 2.54 | 1.64 to 3.44 | ||
| T: 2.52 | 1.57 to 3.46 | ||||
| Mobility | Timed up and go | WF: -1.74 | −2.25 to −0.95 | ||
| T: −2.14 | −3.02 to −1.25 | ||||
| Endurance | 6 minute walk test | WF: 1.86 | 1.05 to 2.66 | ||
| T: 2.39 | 1.47 to 3.31 | ||||
| Freezing of gait | Freezing of gait | WF: 0.85 | 0.14 to 1.55 | ||
| T: 0.76 | 0.03 to 1.49 | ||||
| Tango vs. waltz/foxtrot | Disability | UPDRS | 0.55 | −0.17 to 1.27 | |
| Balance | BBS | −0.09 | −0.80 to 0.61 | ||
| Mobility | TUG | −0.75 | −1.48 to −0.02 | ||
| Endurance | 6MWT | 1.75 | 0.92 to 2.58 | ||
| Freezing of gait | FOG | −0.08 | −0.79 to 0.63 | ||
|
| |||||
| Hackney et al. (2007) [ | Disability (motor) | UPDRS–Motor 3 | 1.53 | 0.51 to 2.55 | 1 hr, 2/week, 13 weeks |
| Balance | Berg balance scale | 3.52 | 2.09 to 4.96 | ||
| Mobility | Timed up and go | −4.78 | −6.54 to −3.01 | ||
| Freezing of gait | Freezing of gait | 1.56 | 0.54 to 2.59 | ||
| Gait velocity | Gait velocity m/s | −1.01 | −1.97 to −0.05 | ||
| Dual tasking | Velocity of dual walking task m/s | −1.11 | −2.08 to −0.05 | ||
|
| |||||
| Hashimoto et al. (2015) [ | Mobility | Time up and go | 0.29 | −0.40 to 0.99 |
|
| Balance | Berg balance scale | 1.49 | 0.71 to 2.28 | ||
| Disability | UPDRS | −0.89 | −1.62 to −0.16 | ||
| Depression | Self-rating depression scale | −0.18 | −0.88 to 0.51 | ||
| PD dance vs. control (usual care) | Mobility | Time up and go | −0.22 | −0.95 to 0.51 |
|
| Balance | Berg balance scale | 1.05 | 0.27 to 1.83 | ||
| Disability | UPDRS | −1.19 | −1.98 to −0.40 | ||
| Depression | Self-rating depression scale | −0.71 | −1.46 to 0.04 | ||
|
| |||||
| Kunkel et al. (2017) [ | Balance | Berg balance scale | −0.01 | −0.62 to 0.59 | 1 hr, 2/week, 10 weeks |
| Mobility | Timed up and go | 0.37 | −0.24 to 0.97 | ||
| Endurance | 6 minute walk test | −0.26 | −0.87 to 0.34 | ||
| Quality of life | PDQ-39 | 0.13 | −0.47 to 0.73 | ||
|
| |||||
| Lee et al. (2015) [ | Balance | Berg balance scale | 1.09 | 0.15 to 2.03 | 30 mins, 5/week, 6 weeks |
| Activities of daily living | Modified Barthel index | 1.12 | 0.18 to 2.07 | ||
| Depression | Beck depression inventory | −1.30 | −2.26 to −0.34 | ||
|
| |||||
| Lee et al. (2018) [ | Disability | UPDRS | −0.36 | −1.00 to 0.27 | 60 min, 2/week, 8 weeks |
| Quality of life | PD quality of life | 0.55 | −0.09 to 1.19 | ||
| Balance | Berg balance sale | 0.38 | −0.25 to 1.01 | ||
| Depression | Beck depression inventory | 0.33 | −1.22 to 0.06 | ||
|
| |||||
| McKee and Hackney (2013) [ | Disability (motor) | UPDRS–Motor 3 | −0.66 | −1.45 to 0.12 | 90 mins, 20 sessions, 12 weeks |
| Balance | Advanced balance scale | 0.32 | −0.45 to 1.09 | ||
| Mobility | Timed up and go | −0.07 | −0.83 to 0.70 | ||
| Quality of life | PDQ-39 | 0.16 | −0.61 to 0.93 | ||
| Freezing of gait | Freezing of gait | −0.27 | −1.00 to 0.53 | ||
|
| |||||
| Michels et al. (2018) [ | Disability (motor) | UPDRS–Motor 3 | −1.32 | -2.60 to −0.03 | 60 mins, 1/week, 10 weeks |
| Disability | UPDRS–Total | −0.61 | −1.81 to 0.59 | ||
| Balance | Berg balance scale | 1.32 | 0.03 to 2.60 | ||
| Mobility | Timed up and go | −1.07 | −2.32 to 0.18 | ||
| Depression | Beck depression inventory | 1.03 | −0.21 to 2.27 | ||
|
| |||||
| Poier et al. (2019) [ | Quality of life | PDQ-39 | −0.14 | −0.87 to 0.59 | 60 min class, 1/week, 10 weeks |
| Satisfaction | BMLSS-life satisfaction | 0.18 | −0.55 to 0.91 | ||
|
| |||||
| Rocha et al. (2018) [ | Mobility | Timed up and go | −0.61 | −1.49 to 0.27 |
|
| Freezing of gait | Freezing of gait | 0.26 | −0.60 to 1.12 | ||
| Balance | Berg balance scale | 0.43 | −0.44 to 1.30 | ||
| Quality of life | PDQ-39 | −0.75 | −1.64 to 0.14 | ||
| Disability (motor) | UPDRS 3 (R) | −0.01 | −0.87 to 0.85 | ||
| Disability (motor) | UPDRS 3 (L) | 0.14 | −0.72 to 0.99 | ||
|
| |||||
| Rio Romenets et al. (2015) [ | Disability | UPDRS-total | −0.50 | −1.19 to 0.20 | 1 hr, 2/week, 12 weeks |
| Disability (motor) | UPDRS 3 | −0.60 | −1.30 to 0.11 | ||
| Quality of life | PDQ-39 | 0.11 | −0.57 to 0.80 | ||
| Mobility | Timed up and go | −1.00 | −1.73 to −0.28 | ||
| Mobility | Dual timed up and go | 0.28 | −0.41 to 0.97 | ||
| Freezing of gait | Freezing of gait | −0.34 | −1.03 to 0.35 | ||
|
| |||||
| Shanahan et al. (2017) [ | Disability (motor) | UPDRS 3 | −1.13 | −1.79 to −0.47 |
|
| Endurance | 6 minute walk test | 0.13 | −0.48 to 0.74 | ||
| Quality of life | PDQ-39 | 0.00 | −0.61 to 0.61 | ||
|
| |||||
| Solla et al. (2019) [ | Disability (motor) | UPDRS–Motor 3 | −1.16 | −2.11 to −0.21 | 90 mins, 2/week, 12 weeks |
| Endurance | 6 minute walk test | 2.57 | 1.38 to 3.75 | ||
| Balance | Berg balance scale | 1.99 | 0.92 to 3.07 | ||
| Mobility | Timed up and go | −1.81 | −2.85 to −0.77 | ||
|
| |||||
| Volpe et al. (2013) [ | Disability (motor) | UPDRS-motor | −0.99 | −1.84 to −0.14 |
|
| Balance | Berg balance scale | 0.81 | −0.02 to 1.64 | ||
| Freezing of gait | Freezing of gait | −1.45 | −2.43 to −0.55 | ||
| Quality of life | PDQ-39 | −0.58 | −1.43 to 0.23 | ||
PDQ-39: Parkinson's Disease Questionnaire-39; PT: physiotherapy; UPDRS: Unified Parkinson's Disease Rating Scale. Analyses were for baseline and after intervention data within groups, unless otherwise specified.
Data analysis for nonrandomised trials.
| Author (lead), year | Dependent variable | Outcome measure | Mean difference (within group: baseline to after intervention) | 95% confidence interval (CI) | Dose of intervention |
|---|---|---|---|---|---|
| Albani et al. (2019) [ | Disability | UPDRS | −3.33 | N/A | Home: 1 hr, 4/week, 5 weeks |
| Quality of life | PDQ-39 | −3.57 | N/A | ||
|
| |||||
| Batson (2010) [ | Mobility | Timed up and go | 0.70 | N/A | 85 min class, 3/week, 3 weeks |
| Balance | Fullerton Advanced Balance Scale | 3.1 | N/A | ||
|
| |||||
| Blandy et al. (2015) [ | Quality of life | EurQol-5D | 0.06 (median) | N/A | 1 hr, 2/week, 4 weeks |
| Depression | Beck Depression Inventory | 4.50 (median) | N/A | ||
|
| |||||
| Dahmen-Zimmer and Jansen (2017) [ | Depression | Hospital Anxiety Depression Scale | ES (between group) 0.61 | −0.22 to 1.45 | 1 hr, 1/week, 30 weeks |
| Wellbeing | SF-12 | ES (between group) −1.02 | −1.88 to −0.15 | ||
|
| |||||
| Delextrant et al. (2016) [ | Aerobic capacity | Mean heart rate | No significant effect of dance style on heart rate ( | N/A | Up to 1 hr, weekly, 6 sessions |
|
| |||||
| Hackney and Earhart (2009) [ | Balance | Berg Balance Scale | 2.80 | N/A | 1.5 hrs, 5/week, 2 weeks |
| Disability (motor) | UPDRS-motor 3 | −4.6 | N/A | ||
| Mobility | Timed up and go | −2.0 (seconds) | N/A | ||
| Endurance | 6-minute walk test | 35.90 (metres) | N/A | ||
|
| |||||
| Hackney and McKee (2014) [ | Balance | Berg Balance Scale | 0.30 | N/A | 1.5 hrs, 2/week, for 12 weeks |
| Mobility | Timed up and go | −0.19 | N/A | ||
|
| |||||
| Heiberger et al. (2011) [ | Disability | UPDRS | 8.2 | N/A | 1/week class, 1.5 hrs, 8 months |
| Mobility | Timed up and go | 0.7 | N/A | ||
|
| |||||
| Kalyani et al. (2019) [ | Quality of life | PDQ39 | ES (between group) 0.23 | −0.46 to 0.91 | 1 hr, 2/week, 12 weeks |
| Disability (ADL) | UPDRS-2 | ES (between group) −0.13 | −0.81 to 0.55 | ||
| Depression | Hospital Anxiety Depression Scale | ES (between group) −0.71 | −1.41 to 0.00 | ||
|
| |||||
| Listewnik and Ossowski (2018) [ | Mobility | Tinetti Performance Oriented Mobility Assessment | 2.15 | N/A | 70 mins, 2/week, for 12 weeks |
| Mobility | Timed up and go | −1.72 | N/A | ||
| Endurance | 6-minute walk test | 85.20 | N/A | ||
|
| |||||
| McGill et al. (2018) [ | Gait | Step variability | ES (between group) 0.70 | −0.03 to 1.42 | 1.25–1.5 hrs, 1/week, for 1 year |
| Gait | Stride variability | ES (between group) 0.62 | −0.10 to 1.34 | ||
| Balance | Activities-Specific BalanceConfidence Scale | ES (between group) 0.24 | −0.47 to 0.95 | ||
|
| |||||
| McKay et al. (2016) [ | Disability (motor) | UPDRS-motor 3 | −2.90 | N/A | 90 mins, 15 lessons over 3 weeks |
| Balance | Berg Balance Scale | 3.80 | N/A | ||
| Endurance | 6-minute walk test | 40.80 | N/A | ||
| Mobility | Timed up and go | −1.10 | N/A | ||
| Freezing of gait | Freezing of gait | 0.10 | N/A | ||
|
| |||||
| McNeely et al. (2015) [ | Disability (motor) | UPDRS-motor 3 | ES (between group) −0.42 | −1.41 to 0.57 | 1 hr group class, 2/week, 12 weeks |
| Quality of life | PDQ-39 | ES (between group) −0.25 | −1.23 to 0.74 | ||
| Mobility | Timed up and go | ES (between group) 0.2 | −0.78 to 1.19 | ||
| Mobility | Dual task timed up and go | ES (between group) 0.42 | −0.57 to 1.41 | ||
| Endurance | 6-minute walk test | ES (between group) −0.39 | −1.38 to 0.60 | ||
|
| |||||
| McRae et al. (2018) [ | Quality of life | Short-Form Health Survey | 3.84 | N/A | 1-2/week, 12 months (6 months–2yrs), session length unknown |
|
| |||||
| Marchant et al. (2010) [ | Disability (motor) | UPDRS-motor 3 | 5.4 | N/A | 10 1.5 hour classes, 2 weeks |
| Endurance | 6-minute walk test | −3.8 | N/A | ||
| Mobility | Timed up and go | −0.5 | N/A | ||
| Balance | Berg Balance Scale | 3.0 | N/A | ||
|
| |||||
| Rawson et al. (2019) [ | Disability (motor) | UPDRS-motor 3 | ES (between group) 1.35 | 0.83 to 1.87 | 1 hr class, 2/week, 12 weeks |
| Endurance | 6-minute walk test | ES (between group) 0.29 | −0.19 to 0.76 | ||
| Quality of life | PDQ-39 | ES (between group) 0.44 | −0.04 to 0.92 | ||
| Tango vs control (stretching) | Disability (motor) | UPDRS-motor 3 | ES (between group) 1.07 | 0.56 to 1.57 | |
| Endurance | 6-minute walk test | ES (between group) −0.80 | −1.29 to −0.31 | ||
| Quality of life | PDQ-39 | ES (between group) 1.14 | 0.63 to 1.65 | ||
|
| |||||
| Seidler et al. (2017) [ | Disability (motor) | UPDRS-motor 3 | ES (between group) 0.22 | −0.66 to 1.10 | 1 hr, 2/week, 12 weeks |
|
| |||||
| Shanahan et al. (2017) [ | Disability (motor) | UPDRS-motor 3 | −2.0 (median) | N/A |
|
| Quality of life | PDQ-39 | −4.03 (median) | N/A | ||
| Endurance | 6-minute walk test | 0.0 | N/A | ||
| Balance | Berg Balance Scale | 1.0 | N/A | ||
|
| |||||
| Tillmann et al. (2020) [ | Beck Depression Inventory | ES (between group) 1.17 | 0.55 to 1.79 | 1 hr, 2/week, 12 weeks | |
|
| |||||
| Tunur et al. (2020) [ | Mobility | Timed up and go | 0.5 | N/A | 3+ modules/day, 3 weeks. |
| Mobility | Dual task timed up and go | −0.5 | N/A | ||
|
| |||||
| Zafar et al. (2017) [ | Participation | Participation and Autonomy Scale | ES (between group) 0.32 | −0.20 to 0.83 | 90 min, 2/week, 12 weeks |
Note: ES, effect size; PDQ-39, Parkinson's Disease Questionnaire-39; UPDRS: Unified Parkinson's Disease Rating Scale Analyses were for baseline and postintervention data within groups, unless otherwise specified.